
ProLogium says it has begun mass-producing all-solid-state cells in Taiwan at 381 Wh/kg, verified by TUV Rheinland and tested against a Chinese all-solid-state standard. Its subsidised Dunkirk gigafactory broke ground in February and its published stag…

The Exploration Company has raised $450m. Most of it goes into something the company is not yet famous for. Not Nyx, the reusable capsule that has drawn the contracts and the SpaceX comparisons. An engine. Kate Duffy reported the round for Bloomberg. F…
Here’s what time Ted Lasso Season 4, Episode 5 “Riches of Embarrassment” comes out on Apple TV, plus the remaining Season 4 release schedule.

China has imposed a cash deposit of up to 99.2% on imports of a Japanese chemical that chip fabs use to build the films inside logic and memory chips. The rate is close to prohibitive. It took effect on Tuesday. China’s Ministry of Commerce published t…

The chief executive of a consultancy with 799,000 staff has described what her clients are telling her about AI, and it is not a sales pitch. “We promised AI can do that,” Julie Sweet told the Wall Street Journal. “And they’re like, we get it, except i…

An Australian company will build data centres in Malaysia and fill them with American chips. It will sell the output to an American company. Its co-chief executive calls this the moment Asia-Pacific stops consuming intelligence and starts producing it….
Netflix’s original movies have not been great lately, but there’s a new film on Netflix’s top 10 list that stars Angelina Jolie that’s getting popular very quickly.
It’s safe to that Brian Baumgartner—who played Kevin Malone on The Office—likes golf. He co-hosts the golf podcast “We Need a Fourth“ But he can find it to be a pain.
A Welsh chipmaker has just posted a 40% jump in revenue. Its shares are up 849% this year. And its chief executive has told an interviewer that the industry has a supply problem it cannot fully solve. Sofia Gerace reported the interview for Bloomberg. …
RevMed’s Rasonque may show our greatest medical advances may become products that society celebrates but increasing numbers of patients cannot obtain.